Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Warner Chilcott UK Limited
1 The Heights, Brooklands, Weybridge, KT12 0NY
Telephone: +44 (0)1932 82 9600
Fax: +44 (0)1932 82 1644
WWW: http://www.wcrx.com
Medical Information Direct Line: +44 (0)800 0328 701
Medical Information e-mail: medcomukir@wcrx.com
Medical Information Fax: +44 (0)1932 824 775

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Summary of Product Characteristics last updated on the eMC: 06/10/2010
SPC Cacit D3 Effervescent Granules 500 mg/440 IU

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 06/10/2010 and displayed until Current
Reasons for adding or updating:
  • Correction of spelling/typing errors
Date of revision of text on the SPC:   01-May-2010
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
None provided
Updated on 24/05/2010 and displayed until 06/10/2010
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 8 - MARKETING AUTHORISATION NUMBER(S)
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   01-May-2010
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company


7.         Marketing Authorisation Holder

 

Warner Chilcott UK Limited

Old Belfast Road,

Millbrook Road,

Larne,

County Antrim,

BT40 2SH

 

8.         Marketing Authorisation Number

 

PL 10947/0017

 

 

 

 

 

10      DATE OF REVISION OF THE TEXT

 

01/05/2010
Updated on 21/03/2006 and displayed until 24/05/2010
Reasons for adding or updating:
  • Change to section 4.4 - Special Warnings and Precautions for Use
Updated on 21/03/2006 and displayed until 21/03/2006
Reasons for adding or updating:
  • Change to section 4.4 - Special Warnings and Precautions for Use
Updated on 20/03/2006 and displayed until 21/03/2006
Reasons for adding or updating:
  • Change to section 4.4 - Special Warnings and Precautions for Use
  • Pending awaiting re-submission
Updated on 31/07/2003 and displayed until 20/03/2006
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
Updated on 27/09/2002 and displayed until 31/07/2003
Reasons for adding or updating:
  • Improved Electronic Presentation

Active Ingredients/Generics

 
  calcium carbonate
  colecalciferol